Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Phase 2 Study of the First Triple-Combination Drug. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 2, p. s17, 2022. DOI: 10.25251/skin.6.supp.17. Disponível em: https://skin.dermsquared.com/skin/article/view/1534. Acesso em: 25 may. 2026.